Dr. Cristina Isabel Tarantola, MD

Dr. Tarantola practices at Tarantola Dermatology Inc in Pensacola, Florida.

Dr. Tarantola's NPI, 1396816765, was assigned on November 10, 2006. Dr. Tarantola graduated from University Of Florida College Of Medicine in 2005. Dr. Tarantola holds Florida license ME112087.

Dr. Tarantola's primary practice is Tarantola Dermatology Inc, at 525 Brent Ln, Pensacola, FL 32503 in Escambia County. The practice phone is (850) 439-5394.

Dr. Tarantola's primary practice is Tarantola Dermatology Inc in Pensacola, Florida. The medical group on file is Tarantola Dermatology. Dmand AI also links Dr. Tarantola to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tarantola practices. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Tarantola's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Tarantola is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Tarantola's licenses on file in 5 states: Florida, Alabama, Missouri, Arizona and Minnesota.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, hives and itchy rashes among the conditions Dr. Tarantola treats.

CMS data shows 11,991 Medicare services from Dr. Tarantola across 39 procedure codes in 2024, for 1,363 Medicare patients. Medicare paid $1,634,316 for them. Every service was in an office.

CMS counts 1,363 Medicare patients who saw Dr. Tarantola in 2024. The largest group is 65 to 74, with 614 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tarantola's median patient age at 72, with 55% women.

In 2024, Dr. Tarantola wrote 798 Medicare Part D claims for 373 patients. 98% of them were for generic drugs. CMS names the drug for 700 of them, across 9 drugs with 11 or more claims each, at $13,429 in total drug cost. In 2023, CMS named 504 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Tarantola for performance year 2024, reported individually. Dr. Tarantola accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 2,676 procedures of removal of skin lesions by Dr. Tarantola, more than 99% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 27 general payments to Dr. Tarantola from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Abbvie Inc. paid the most, $559.

Dmand AI lists 2 awards for Dr. Tarantola.

Dr. Tarantola graduated from University Of Florida College Of Medicine in 2005. Dr. Tarantola is a member of AAD.

Dr. Tarantola is in network with 11 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.